World's largest drug companies investigated for Alzheimer's fraud
William Campbell Douglass II, M.D.
There are two sets of pockets you should never look inside -- a five-year-old boy's and a drug company's. In one you might find a toad, and in the other you might find a corrupt medical researcher.
And they're both pretty disgusting to me.
Japan's Health Ministry fired the shot heard round the world recently when it announced it was investigating several of the world's largest drug companies after accusations of falsifying data in a government-funded study on Alzheimer's disease.
The list of accused cheaters reads like a "Who's Who In Big Pharma." Eleven drug firms in all, including Pfizer, Bristol-Myers Squibb, Takeda Pharmaceutical, and Astellas Pharma will now undergo the Japanese equivalent of a full rectal exam after a Tokyo professor accused them of fudging numbers to help advance drug company interests.
Japan ponied up $28 million in taxpayer cash for the research, which was supposed to improve Alzheimer's treatment and diagnosis. They even let some drug company scientists in on the study -- and that's when things seemed to fall apart. Because instead of working on behalf of the Japanese taxpayers, as they were supposed to do, it seems all these scientists cared about was making their employers more cash.
All it took was one brave whistleblower to come forward, and the whole house of cards came crumbling down. And if what he's saying is true, this could be one of the greatest instances of research fraud ever to be exposed in Big Pharma's long and filthy history.
You see, this supposed fraud wasn't being carried about by some poor, misguided soul looking to score brownie points with his drug company boss. According to a special report in one of Japan's largest newspapers, there were AT LEAST four separate instances of researchers linked to drug companies and medical institutions trying to falsify data.
This looks systematic and organized. And, sadly, it's not surprising at all.
Let's face it -- this isn't exactly the first time Big Pharma has been accused of cooking the books. And how many times have they brought a drug to market based on safety data that turned out to be wishful thinking at best -- and fraud at worst?
The Japanese don't take shame sitting down, so if any drug company execs are thinking about committing hara-kiri, now would be the time. And I think I speak for billions of victimized patients and taxpayers everywhere when I say they won't be missed.